These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11292885)

  • 21. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
    Campion M; Scully G
    J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of pharmacy services in a telemedicine intensive care unit.
    Meidl TM; Woller TW; Iglar AM; Brierton DG
    Am J Health Syst Pharm; 2008 Aug; 65(15):1464-9. PubMed ID: 18653818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial stewardship in the intensive care unit: a focus on potential pitfalls.
    Njoku JC; Hermsen ED
    J Pharm Pract; 2010 Feb; 23(1):50-60. PubMed ID: 21507793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic usage and prescribing policies in the intensive care unit.
    Emmerson M
    Intensive Care Med; 2000; 26 Suppl 1():S26-30. PubMed ID: 10786955
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients.
    Forni A; Skehan N; Hartman CA; Yogaratnam D; Njoroge M; Schifferdecker C; Lilly CM
    Ann Pharmacother; 2010 Mar; 44(3):432-8. PubMed ID: 20164471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of infections caused by drug-resistant organisms in critical care.
    Hoppe B
    Am J Crit Care; 1997 Mar; 6(2):141-4. PubMed ID: 9172851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Appropriate use of antibiotics--practices we should employ now: appropriate use of antibiotics for pharmacists in general hospitals].
    Yamada K
    Rinsho Byori; 2010 Jul; 58(7):706-10. PubMed ID: 20715514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: a survey of 250 critical care pharmacists from eight states.
    Devlin JW; Bhat S; Roberts RJ; Skrobik Y
    Ann Pharmacother; 2011 Oct; 45(10):1217-29. PubMed ID: 21934036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit.
    Raineri E; Pan A; Mondello P; Acquarolo A; Candiani A; Crema L
    Am J Infect Control; 2008 May; 36(4):283-90. PubMed ID: 18455049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of SDD on ICU ecology.
    van Saene HK; Alcock SR; Rommes JH; Baxby D; Percival A
    Intensive Care Med; 1994 Jul; 20(6):459-60. PubMed ID: 7798457
    [No Abstract]   [Full Text] [Related]  

  • 32. Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership.
    Goldmann DA; Weinstein RA; Wenzel RP; Tablan OC; Duma RJ; Gaynes RP; Schlosser J; Martone WJ
    JAMA; 1996 Jan; 275(3):234-40. PubMed ID: 8604178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of web services for computerized medical decision support, including infection control and antibiotic management, in the intensive care unit.
    Steurbaut K; Van Hoecke S; Colpaert K; Lamont K; Taveirne K; Depuydt P; Benoit D; Decruyenaere J; De Turck F
    J Telemed Telecare; 2010; 16(1):25-9. PubMed ID: 20086264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
    Vincent JL; Bihari DJ; Suter PM; Bruining HA; White J; Nicolas-Chanoin MH; Wolff M; Spencer RC; Hemmer M
    JAMA; 1995 Aug 23-30; 274(8):639-44. PubMed ID: 7637145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of pharmacist management of pain, agitation, and delirium in the intensive care unit through participation in multidisciplinary bundle rounds.
    Louzon P; Jennings H; Ali M; Kraisinger M
    Am J Health Syst Pharm; 2017 Feb; 74(4):253-262. PubMed ID: 28179250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit.
    Jacoby TS; Kuchenbecker RS; Dos Santos RP; Magedanz L; Guzatto P; Moreira LB
    J Hosp Infect; 2010 May; 75(1):23-7. PubMed ID: 20338669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surviving Sepsis in the Intensive Care Unit: The Challenge of Antimicrobial Resistance and the Trauma Patient.
    Ramsamy Y; Hardcastle TC; Muckart DJJ
    World J Surg; 2017 May; 41(5):1165-1169. PubMed ID: 27146052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of clinical pharmacist interventions in an intensive care unit.
    Hassan Y; Aziz NA; Awang J; Aminuldin AG
    J Clin Pharm Ther; 1992 Dec; 17(6):347-51. PubMed ID: 1287026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines on antimicrobial chemotherapy for prevention and treatment of infections in the intensive care unit.
    Bergogne-Bérézin E
    J Chemother; 2001 Nov; 13 Spec No 1(1):134-49. PubMed ID: 11936358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.